Brief: Emcure Pharmaceuticals March-Quarter Consol Net Profit 2.43 Billion Rupees
05/05/2026 10:35
May 5 (Reuters) - Emcure Pharmaceuticals Ltd EMCU.NS: EMCURE PHARMACEUTICALS MARCH-QUARTER CONSOL NET PROFIT 2.43 BILLION RUPEES EMCURE PHARMACEUTICALS MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 24.7 BILLION RUPEES EMCURE PHARMACEUTICALS LTD - RECOMMENDS FINAL DIVIDEND OF 3.60 RUPEES PER SHARE FOR FY ENDED MARCH 31, 2026 EMCURE PHARMACEUTICALS LTD - RE-APPOINTMENT OF SATISH MEHTA AS MD Source text: [ID:] Further company coverage: EMCU.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Emcure Pharmaceuticals
See all newsIndia's Emcure Pharma rises on Poviztra approval, Motilal initiation with 'buy'
Brief: Emcure Pharmaceuticals Ltd To Expand Use Of Poviztra For Mash Indication Following CDSCO Approval
Brief: Emcure Pharmaceuticals Says Kuber Jagdale, President, API Business, Superannuates
India's Emcure Pharma hits record high after Jefferies raises TP
Brief: Emcure Pharmaceuticals March-Quarter Consol Net Profit 2.43 Billion Rupees